HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Ulta: ‘Natural Look’ Trend Slowing Makeup Sales, But Offers Room To Innovate

Executive Summary

With color cosmetics sales on the decline in the US, retailer Ulta Beauty is confident marketers can inject some excitement and innovation into the category, but acknowledges the shift may take some time.

You may also be interested in...



Ulta Shines Through Storm Clouds In 2019, Enters Shadow Of COVID-19

Ulta Beauty booked a 10% increase in net sales in fiscal 2019 despite a grinding makeup category slowdown. The retailer expects continued growth, albeit somewhat moderated, in 2020 – at least before coronavirus impacts admittedly “very difficult to predict or quantify.”

Coty’s $600m Kylie Cosmetics Bet Has Analysts Nervous, But ‘We Don’t See Weaknesses,’ CFO Says

Coty is confident that it can build Kylie Cosmetics into a global powerhouse. However, some analysts have misgivings about the firm’s heavy investment in a celebrity brand, questioning whether its success could be a fad and noting Coty’s “poor track record” with acquisitions overall.

Women’s Voices For The Earth Will Keep After CIR, Salon Worker Safety In 2024

Women’s Voices for the Earth continues to call attention to cosmetic ingredients’ potential health impacts on users including salon workers, while pushing the Cosmetic Ingredient Review to consider a wider variety of safety information in its assessment work.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS149521

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel